These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 4959277)

  • 21. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.
    Mattioli M; Reichlin M
    J Immunol; 1971 Nov; 107(5):1281-90. PubMed ID: 4330162
    [No Abstract]   [Full Text] [Related]  

  • 22. Presence of hepatitis-associated antigen in systemic lupus erythematosus.
    Alarcón-Segovia D; Fishbein E; Díaz-Jouanen E
    Clin Exp Immunol; 1972 Sep; 12(1):9-19. PubMed ID: 4538860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on nucleoprotein determinants for systemic lupus erythematosus serum.
    Stollar BD
    J Immunol; 1967 Nov; 99(5):959-65. PubMed ID: 5299610
    [No Abstract]   [Full Text] [Related]  

  • 24. Deoxyribonucleic acid and its antibodies in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1981 Dec; 22(6):323-31. PubMed ID: 7038879
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical interest and practical modalities of research on anti- native and denatured desoxyribonucleic acid (DNA) antibodies].
    Cannat A; Arana R; Seligmann M
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):1015-20. PubMed ID: 4970706
    [No Abstract]   [Full Text] [Related]  

  • 26. Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.
    Agnello V; Winchester RJ; Kunkel HG
    Immunology; 1970 Dec; 19(6):909-19. PubMed ID: 4098878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to ribonucleic acid in systemic lupus erythematosus.
    Schur PH; Monroe M
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1108-12. PubMed ID: 5260912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic and prognostic significance of complement fixing anti-n-DNA antibodies in systemic lupus erythematosus].
    Pozzoli R
    Quad Sclavo Diagn; 1987 Mar; 23(1):65-71. PubMed ID: 3441594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Binding of complement by anti-native desoxyribonucleic acid antibodies in systemic lupus erythematosus].
    Youinou P; Le Goff P; Jouquan J; Cledes J; Pennec Y; Mottier D; Abgrall JF; Tandé D; Cam P; Le Menn G
    Presse Med; 1985 Apr; 14(16):875-8. PubMed ID: 3158921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The reactivity of lupus erythematosus serum with native and denatured DNA of various origins].
    Störl HJ; Barthelmes H
    Acta Biol Med Ger; 1975; 34(6):951-7. PubMed ID: 53975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.
    Tan EM; Kunkel HG
    J Immunol; 1966 Mar; 96(3):464-71. PubMed ID: 5932578
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating immune complexes and the complements system in lupus nephropathy.
    Serban MG
    Rom J Intern Med; 1992; 30(2):119-25. PubMed ID: 1496264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin G subclass of human antinuclear antibodies.
    Tojo T; Friou GJ; Spiegelberg HL
    Clin Exp Immunol; 1970 Jan; 6(1):145-51. PubMed ID: 4984586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.
    Sharp GC; Irvin WS; LaRoque RL; Velez C; Daly V; Kaiser AD; Holman HR
    J Clin Invest; 1971 Feb; 50(2):350-9. PubMed ID: 4992992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australia antigen in systemic lupus.
    Alarcón-Segovia D; Fishbein E
    N Engl J Med; 1971 Feb; 284(8):448. PubMed ID: 4993111
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibodies against native (double-strand) deoxyribonucleic acid and complement fixing antibodies in generalized lupus erythematosus with affected kidneys].
    Dostál C; Hána I; Bardfeld R; Stejskal J; Matl I; Zvárová J
    Vnitr Lek; 1984 May; 30(5):417-25. PubMed ID: 6331681
    [No Abstract]   [Full Text] [Related]  

  • 37. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera.
    Shrier DA; Taniguchi O; Barnett EV
    J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The appearance of leukocyte and thrombocyte antibodies in internal diseases].
    Leverenz S; Konrad H; Schulz K; Nowotny P
    Allerg Asthma (Leipz); 1969; 15(3):129-40. PubMed ID: 4984399
    [No Abstract]   [Full Text] [Related]  

  • 39. On the significance of the anti-muscle and erythrocyte membrane factors in systemic lupus erythematosus.
    Arimori S; Nakata Y
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):970-5. PubMed ID: 4633772
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinico-immunological parallels in systemic lupus erythematosus].
    Drampian FS; Aznaurian AV
    Zh Eksp Klin Med; 1971; 11(1):101-4. PubMed ID: 5315376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.